Showing results (161-170 of 226) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2019
Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly TrialHanneke C Kluin-Nelemans, Eva Hoster, Olivier Hermine, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 3, 2021
Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangementsJ J Eertink, A I J Arens, J E Huijbregts, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2019
Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysisYvonne W S Jauw, Frederike Bensch, Adrienne H Brouwers, et al.
JAMA Oncology|February 2, 2023
Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin LymphomaYvonne M Geurts, Rebecca Shakir, Georgios Ntentas, et al.
Blood Advances|October 28, 2022
Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphomaJakoba J Eertink, Gerben J C Zwezerijnen, Sanne E Wiegers, et al.
The Lancet. Oncology|January 12, 2019
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup studyJacoline E C Bromberg, Samar Issa, Katerina Bakunina, et al.
EJNMMI Research|November 28, 2025
Predicting 2-year time to progression in diffuse large B cell lymphoma using 3D CNNs on whole-body PET/CT scansMaria C Ferrández, Sanne E Wiegers, Gerben J C Zwezerijnen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2024
Validation of an Artificial Intelligence-Based Prediction Model Using 5 External PET/CT Datasets of Diffuse Large B-Cell LymphomaMaria C Ferrández, Sandeep S V Golla, Jakoba J Eertink, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2025
Measuring Total Metabolic Tumor Volume from 18F-FDG PET: A Reality CheckRonald Boellaard, Gerben J C Zwezerijnen, Irène Buvat, et al.
Pageof 23